Mitre, AtrocityWatch Sign Analytics Tech License Agreement; Mark Maybury Comments

Big Data, AppsAtrocityWatch has licensed a social analytics technology from Mitre Corp. in an effort to help peacekeepers forecast humanitarian atrocities globally.

Mitre said Wednesday the nonprofit organization intends to use the platform to detect early indicators of war crimes, genocide and other crimes against humanity.

“We are honored to see MITRE’s vision and pioneering research in social radar applied to a humanitarian application that has the potential to make the world a better place,” said Mark Maybury, a vice president and chief technology officer of Mitre.

Geoff Green, founder of AtrocityWatch, said Mitre’s technology is designed to analyze events, topics and sentiments on social media.

The organization has also been selected to receive pro bono professional services from Deloitte through the company’s Humanitarian Innovation Program.

You may also be interested in...

Blue Origin

Blue Origin Launches 14th New Shepard Mission With Updated Crew Capsule

Blue Origin, a space company owned by Amazon CEO Jeff Bezos, used a capsule with updated crew systems during the company's 14th mission with the New Shepard rocket. The updated capsule featured new push-to-talk communications systems, noise reduction tools, cushioned wall linings, environmental systems and a crew alert system, Blue Origin said Thursday.

Teledyne

Teledyne Subsidiary to Produce Additional Navy LCS Missile Defense Modules

A Teledyne Technologies subsidiary has secured an $18M contract from Northrop Grumman to manufacture four more missile defense systems for the U.S. Navy's littoral combat ship mission package.

Orion

Lockheed’s Orion Spacecraft Concludes Assembly, Testing for NASA’s Artemis Mission to Lunar Orbit

Lockheed Martin has sent the Orion capsule to NASA’s exploration ground systems team for final preparations ahead of the unmanned Artemis I mission to lunar orbit that will launch later this year. The spacecraft concluded assembly operations and testing at Kennedy Space Center in Florida.